ArticleScientific reports2021

Immunocompatibility of a new dual modality contrast agent based on radiolabeled iron-oxide nanoparticles.

Maria-Argyro Karageorgou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.